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Abstract
Whole-genome sequencing of Mauritian cynomolgus
macaques reveals novel candidate loci for controlling
simian immunodeficiency virus replication.
Research highlight
Multiple factors influence the progression of an HIV-
positive individual to acquired immune deficiency syn-
drome (AIDS); these include, their general health, the
route of exposure and the specific HIV strain are a few
examples of factors that can impact how long the virus
remains latent in the body before the clinical manifest-
ation of AIDS. Aside from these environmental factors,
there also seem to be important host genetic contri-
butions. Some individuals, termed ‘elite controllers’ or
‘long-term non-progressors’, can harbor the virus for an
extended period of time without developing AIDS, even
in the absence of treatment. Understanding the under-
lying genetic changes that define these individuals could
suggest new treatment strategies or improve the devel-
opment of vaccines.
Animal models minimize the contribution of environ-
mental factors and can thus exaggerate genetic effects.
This makes them ideal for identifying genetic causes of
complex phenotypes. In this issue of Genome Biology,
Ericsen and colleagues use whole-genome sequencing of
Mauritian cynomolgus macaques (Macaca fascicularis)
to identify candidate loci affecting the control of simian
immunodeficiency virus (SIV) [1]. Using animals from
previous work, whole-genome sequencing enabled the
identification of seven candidate control regions that
merit further study. Perhaps more importantly, however,
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the work demonstrates the utility of whole-genome se-
quencing in non-human primates in several important
respects: for improving our understanding of the gen-
etic basis of disease, for refining animal models, for in-
creasing translational meaning and for reducing
unnecessary studies.
An animal model of AIDS
In 1982, veterinarians at the New England Primate Re-
search Center recognized an increase in the number of
deaths associated with immunosuppression in their ma-
caque colonies. As they reviewed the case-history for
these animals, it became apparent that there were strong
similarities between the disease they were seeing and the
burgeoning AIDS epidemic [2]. At the time, the etiologic
agent of the disease, in humans and in macaques, was
unknown. This would change quickly; in the next two
years, researchers successfully isolated a T-cell-tropic
retrovirus from macaques that had died from this AIDS-
like disease [3]. Shortly thereafter, they were able to in-
duce the disease state in macaques through inoculation
with the virus, conclusively identifying the agent of the
disease and developing the first animal model of human
AIDS [4]. Since those early years, macaques have be-
come the best model of HIV/AIDS and have greatly fur-
thered our understanding of the disease [5].
SIV is part of a broader group of lentiviruses that in-
cludes feline, bovine, ovine/caprine, and equine relatives
[6]. Over 40 species of African primates are endemically
infected with various strains of SIV. The most notable
examples are chimpanzees and sooty mangabeys, in which
HIV-1 and HIV-2, respectively, originated. In their natural
hosts, the SIV viruses are generally not pathogenic (SIVcpz
is a notable counterexample); this is due to coevolution of
the virus and host immune systems [7]. However, when
these viruses cross species boundaries into non-native
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happened with the introductions into humans and is also
what we observe in the Asiatic macaques. The SIV that af-
fects these macaques, like HIV-2, seems to have originated
from an endogenous sooty mangabey virus.
The Asiatic macaques, including both the commonly
used rhesus macaque (Macaca mulatta) as well as the
cynomolgus macaque M. fascicularis, are useful models
for human HIV infection and progression to AIDS be-
cause they too are not naturally occurring hosts, are sus-
ceptible to infection by closely related viruses and show
similar symptomology and disease progression to that in
humans. These factors mean that they are useful not
only for understanding host-virus interactions but also
for studying post-infection treatment and vaccine-
development options. Together, this places an incredible
importance on non-human primate models for HIV/
AIDS research that cannot be recapitulated in other
model organisms (such as rodents), in cell-culture sys-
tems or in humans.
An audience with the Red Queen
Over the past two decades, a number of host genetic
factors have been identified that affect susceptibility to
infection with HIV and disease progression. This in-
cludes both genetic factors in natural hosts, which ul-
timately result in the non-pathogenicity of their resident
viruses, as well as those in humans and macaques that
impact the course of disease. In early studies, alleles for
human leukocyte antigen (HLA) were identified that in-
fluence the course of HIV infection [8]. The pervasive
importance of HLA alleles in infectious disease has long
been well established, and this signal is regularly and
consistently observed in association with diseases with
an infectious or inflammatory component. Since then, a
number of additional host genes have been identified,
with differing levels of confidence (reviewed in [9]).
Identification of genetic factors has largely come either
from human genome-wide association studies (GWAS)
or from candidate-gene studies in non-human primates.
For HIV/AIDS, the same issues that regularly plague
human GWAS are found; few loci reach genome-wide
significance, and those that do tend to recapitulate pre-
viously known effects (notably HLA) without many un-
ambiguous novel findings. Candidate-gene studies in
non-human primates have been more useful in identi-
fying novel targets. These have largely made use of our
existing knowledge of the mechanisms by which SIV
enters the cell and through extrapolations from cell-
culture experiments. Until now, these two approaches
had not intersected.
In this month’s paper, Ericsen and colleagues [1] offer
the first application of whole-genome sequencing
to interrogating SIV progression in macaques. Their
genome-wide analysis offers seven novel candidate loci
for host control of SIV replication, identifying unique
and previously uninterrogated regions for further study.
Taken alone, this represents seven potential new targets
for therapeutic development and seven potential new foot-
holds for furthering our understanding of disease. With
the devastation wrought by HIV/AIDS, this represents a
potentially meaningful advance by itself. It is equally note-
worthy, however, that this represents a new step forward
more broadly.
Two scientific criticisms of non-human primate re-
search are consistently voiced, especially by those used
to dealing with rodent studies: first, that monkeys are
outbred and genetically heterogeneous (which intro-
duces genetic variability, and makes mapping difficult);
and second, that, for a variety of reasons, sample sizes
are often small. This study takes advantage of the genetic
variation inherent in cynomolgus macaques to identify
novel loci in a forward-genetic approach. The lack of an
existing comprehensive map of genetic variation makes
whole-genome sequencing necessary but, in turn, ensures
a minimum of ap r i o r ibias. Cleverly, the authors first seg-
regate animals by major histocompatibility (MHC) type,
both offering an internal positive control for their meth-
odology and eliminating a previously known control locus
whose signal has the potential to drown out any new find-
ings. As a result of this care, as well as the substantial en-
vironmental control afforded by animal studies, genetic-
effect sizes are maximized and the small study size is not
prohibitive. Taken as a whole, this study demonstrates the
power of non-human primate studies and shows how
common criticisms can be overcome, even in whole-
genome studies.
A wheel still in spin
The work by Ericsen and colleagues [1] represents the
first actual implementation of a future that many in the
non-human primate genetics community have long envi-
sioned [9,10]. It brings non-human primate research into
the post-genomic era, finally fully realizing the advan-
tages of the model. It also builds upon decades of pre-
vious non-human primate research on SIV. Over the
years, the macaque SIV model has seen extensive use in
studies of the basic biology of the disease as well as in
vaccine and treatment development. For many of these
studies, detailed records that describe the differing re-
sponses of individual animals are available, as well as
blood, tissue samples or isolated genomic DNA. Now
that whole-genome sequencing is finally a reality, these
historic studies can be subjected to modern and rigorous
genetic interrogation.
The new work [1] offers a guidepost to how this might
be done. It carefully selects animals a priori on known
genetic factors and on previously determined responses
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density of heterozygous variation between groups that
differed in their ability to control viral replication after
52 weeks, it was possible to identify regions where the
two groups differed and where, potentially, there might
exist novel host control factors. In the future, this ap-
proach can be expanded and adapted to achieve greater
power.
While this study separates elite controllers from stand-
ard progressors in the search for host determinants of
SIV replication, it could just as easily be applied to other
disparate classes of animals: those with behavioral ab-
normalities, those that respond differently to pharma-
ceuticals or drugs of abuse, or those that show more
pronounced cognitive decline with aging. The entire
realm of non-human primate models for which there
exist genetic components is potentially amenable to this
approach. Specifically, in the context of understanding
host control of SIV, sequencing of additional animals
will further narrow and refine the list of candidate genetic
loci and, as additional functional genetic regions are iden-
tified, further a priori segregated groups can be studied.
Finally, of course, as more animals that are suitable for
genetic follow-up studies are identified, other methodolo-
gies for dealing with the whole-genome sequencing data
will become available.
This moment has long been on the horizon, a realization
of the promise of the post-genomic era for understanding
the genetic causes of complex disease. In human studies,
this vision has generally proven illusory as a result of en-
vironmental variation and uncontrolled, or uncontrollable,
variables, save for rare exceptions. Now, however, Ericsen
and colleagues have produced a practical, workable,
approach utilizing non-human primates [1]. The road
forward is clear, and it is now only up to the research
community to take advantage.
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